Skip to main content
Log in

Mindray 3-directional NMT Module (a new generation “Tri-axial” neuromuscular monitor) versus the Relaxometer mechanomyograph and versus the TOF-Watch SX acceleromyograph

  • Original Research
  • Published:
Journal of Clinical Monitoring and Computing Aims and scope Submit manuscript

A Correction to this article was published on 26 February 2019

This article has been updated

Abstract

Recently introduced Mindray “3-directional” neuromuscular transmission transducer (NMT, Shenzhen, China) acceleromyograph) claim to monitor thumb movement in 3 different directions. We compared NMT with the gold standard Relaxometer® mechanomyograph (MMG, Groningen University, Netherlands) in Study-1 and with TOF-Watch SX™ (WTCH) acceleromyograph from which it was developed in Study-2. We used first twitch (T1%) and train-of-four (TOF) ratio rocuronium 0.6 mg kg−1 neuromuscular block to evaluate NMT diagnostic accuracy in indicating 3 clinically relevant time points namely; MMG T1 5% (95% twitch depression) for tracheal intubation, MMG T1 25% for repeat neuromuscular blocking agents (NMBAs) administration, and MMG 0.9 TOF ratio full neuromuscular block recovery. We compared onset time (time from beginning of rocuronium administration until maximal depression), Dur25 (time until T1 25% recovery) and Dur0.9 (time until 0.9 TOF ratio recovery). In Study-1, NMT showed low sensitivity in indicating MMG time for tracheal intubation, repeat NMBAs administration and full neuromuscular block recovery (6.25%, 38.9% and 38.9% respectively). NMT onset time, Dur25 and Dur0.9 (2:51 ± 00:57, 36:50 ± 24:25, 70:08 ± 25:27 min:s) were significantly longer than MMG (1:56 ± 00:46, 30:26 ± 20:24, 62:03 ± 20:01). In Study-2, NMT onset time, Dur25 and Dur0.9 (02:37 ± 00:53, 35:38 ± 11:54, 53:40 ± 13:49) were not significantly different than WTCH (02:23 ± 00:45, 33:27 ± 12:51, 53:57 ± 12:47). NMT could not efficaciously detect MMG time for tracheal intubation; NMBAs repeat dose administration or full neuromuscular block recovery. Data from NMT cannot be used interchangeably with MMG. Our study revealed that NMT Tri-axial acceleromyography seems to offer no advantage over the MMG gold standard or the classic Mono-axial TOF-Watch SX monitor.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Change history

  • 26 February 2019

    In the original publication of the article, the article note “Ashraf A. Dahaba and Zhao Yang Xiao equally contributed to the study and are both first authors.” was published incorrectly. The correct statement should read as “Ashraf A. Dahaba and Zhao Yang Xiao equally contributed to the study and are both first authors and are both co-corresponding authors.”

References

  1. Fuchs-Buder T, Claudius C, Skovgaard LT, et al. Good Clinical research Practice (GCRP) in pharmocodynamic studies of neuromuscular blocking agents II: the Stockholm revision. Acta Anaesthesiol Scand. 2007;51:789–808.

    Article  CAS  PubMed  Google Scholar 

  2. Loan PB, Paxton LD, Mirakhur RK, Connolly FM, McCoy EP. The TOF-Guard neuromuscular transmission monitor. A comparison with the Myograph 2000. Anaesthesia. 1995;50:699–702.

    Article  CAS  PubMed  Google Scholar 

  3. Claudius C, Viby-Mogensen J. Acceleromyography for use in scientific and clinical practice. A systematic review of the evidence. Anesthesiology. 2008;108:1117–40.

    Article  PubMed  Google Scholar 

  4. Bossuyt PM, Reitsma JB, Bruns DE, et al. The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Clin Chem. 2003;49:7–18.

    Article  CAS  PubMed  Google Scholar 

  5. Rowaan CJ, Vandenbrom RHG, Wierda JMKH. The Relaxometer: a complete and comprehensive computer-controlled neuromuscular transmission measurement system developed for clinical research on muscle relaxants. J Clin Monit. 1993;9:38–44.

    Article  CAS  PubMed  Google Scholar 

  6. Dahaba AA, Prax N, Gaube W, et al. Haemodynamic and catecholamine stress responses to Laryngeal Tube-Suction Airway and the Proseal Laryngeal Mask Airway. Anaesthesia. 2006;61:330–4.

    Article  CAS  PubMed  Google Scholar 

  7. Kopman AF, Kumar S, Klewicka MM, Neuman GG. The staircase phenomenon. Implications for monitoring of neuromuscular transmission. Anesthesiology. 2001;95:403–7.

    Article  CAS  PubMed  Google Scholar 

  8. Fisher DM, Shafer SL. Walk a mile in my shoes. Anesth Analg. 2010;111:264–5.

    Article  PubMed  Google Scholar 

  9. Agoston S. Onset time and evaluation of intubating conditions: rocuronium in perspective. Eur J Anaesth. 1995;12(Suppl. 11):31–7.

    Google Scholar 

  10. Dahaba AA, Klobucar F, Rehak PH, List WF. The Neuromuscular Transmission Module (M-NMT) Vs. the Relaxometer Mechanomyograph for neuromuscular block monitoring. Anesth Analg. 2002;94:591–6.

    Article  PubMed  Google Scholar 

  11. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1(8476):307–10.

    Article  CAS  PubMed  Google Scholar 

  12. Myles PS, Cui J. Using the Bland–Altman method to measure agreement with repeated measures. Br J Anaesth. 2007;99:309–11.

    Article  CAS  PubMed  Google Scholar 

  13. Hemmerling TM, Schmidt J, Hanusa C, Wolf T, Schmitt H. Simultaneous determination of neuromuscular block at the larynx, diaphragm, adductor pollicis, orbicularis oculi and corrugator supercilii muscles. Br J Anaesth. 2000;85:856–60.

    Article  CAS  PubMed  Google Scholar 

  14. Viby-Mogensen J, Jensen E, Werner MU, Nielsen HK. Measurement of acceleration: a new method of monitoring neuromuscular function. Acta Anaesthesiol Scand. 1988;32:45–8.

    Article  CAS  PubMed  Google Scholar 

  15. Harper NJN, Martlew R, Strang T, Wallace M. Monitoring neuromuscular block by acceleromyography: comparison of the Mini-Accelograph with the Myograph 2000. Br J Anaesth. 1994;72:411–4.

    Article  CAS  PubMed  Google Scholar 

  16. Dahaba AA, Rehak PH, List WF. Assessment of Accelerography with the TOF-GUARD. A comparison with electromyography. Eur J Anaesth. 1997;14:623–9.

    Article  CAS  Google Scholar 

  17. Dubois PE, Gourdin M, Russell K, Jamart J. Installation of the hand influences acceleromyography measurement. A comparison with mechanomyography during neuromuscular recovery. Acta Anaesthesiol Belg. 2005;56:163–6.

    PubMed  Google Scholar 

  18. Dahaba AA, Klobucar F, Rehak PH, List WF. Comparison of a new piezoelectric train-of-four neuromuscular monitor, the ParaGraph, and the Relaxometer mechanomyograph. Br J Anaesth. 1999;82:780–2.

    Article  CAS  PubMed  Google Scholar 

  19. Kern SE, Johnson JO, Westenskow DR, Orr JA. An effectiveness study of a new piezoelectric sensor for train-of-four measurement. Anesth Analg. 1994;78:978–82.

    Article  CAS  PubMed  Google Scholar 

  20. Suzuki T, Fukano N, Kitajima O, Saeki S, Ogawa S. Normalization of acceleromyographic train-of-four ratio by baseline value for detecting residual neuromuscular block. Br J Anaesth. 2006;96:44–7.

    Article  CAS  PubMed  Google Scholar 

  21. Hemmerling TM, Le N. Brief review: Neuromuscular monitoring: an update for the clinician. Can J Anaesth. 2007;54:58–72.

    Article  PubMed  Google Scholar 

  22. Kopman AF, Kopman DJ. An analysis of the TOF-watch algorithm for modifying the displayed train-of-four ratio. Acta Anaesthesiol Scand. 2006;50:1313–4.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

All authors would like to thank Mr. Elfid Pasovic our freelancer computer specialist at Sarajevo, Bosnia and Herzegovina for his great efforts in the data preparation and patients’ data management. Thanks to him we have all the patients data successfully recorded and downloaded. We would like also to thank graduate student Miss Fengyan Xu at Shanghai, People’s Republic of China for her great efforts in data preparation and statistical analysis.

Clinical trial registry numbers Our clinical trial was registered by Primary Investigator: Ashraf Dahaba prior to patient enrollment at Food and Drug Administration Clinical Trials Database www.ClinicalTrials.gov; trial Registration Number: NCT02892045. Date of registration: protocol record NMT1 released and made public on 8th September 2016 on www.ClinicalTrials.gov. Sarajevo Medical University, Sarajevo Bosnia and Herzegovina ethics committee approval (0406-19256 at 5th May 2016 meeting chaired by Doc. Dr. Sci. Med Jasmina Krehic), and Dalian University Second affiliated Hospital ethics committee Dalian, People’s Republic of China (2015-106 at 14th January 2016 meeting chaired by Prof Dr. Ren Ping), Dalian, People’s Republic of China.

Funding

The study was financed from National Natural Science Foundation of China (Beijing, People’s Republic of China), grant No: 81471373, and the National Natural Science Foundation of China (Beijing, People’s Republic of China), Grant No: 81071052, both grants awarded to Professor Dr. Zhao Yang Xiao, Department of Anesthesiology, Xijing First Affiliated Hospital of Fourth Military Medical University, Xi’an, Shaanxi, and Department of Emergency Intensive Care Unit, Second Affiliated Hospital of Dalian Medical University, Dalian, People’s Republic of China.

Author information

Authors and Affiliations

Authors

Contributions

Primary investigator AAD conducted the study, participated in data collection, data analysis and manuscript writing. IS participated in perioperative anesthesia management, conducting the study, data collection, data analysis and manuscript writing. ZX participated in perioperative anesthesia management, conducting the study, data collection, data analysis and manuscript writing. KW is the statistician who designed the Bland and Altman scatterplots and regression plots as well as statistical analysis.

Corresponding author

Correspondence to Ashraf A. Dahaba.

Ethics declarations

Conflict of interest

All authors attest to the validity and legitimacy of the data and its interpretation, and agree to its submission. All authors have significantly contributed to the manuscript and no person or group of persons who actively contributed were excluded from the study. All authors confirm that they have read and approved the paper, have met the criteria for authorship as established by the International Committee of Medical Journals Editors, believe that the paper represents honest work, and are able to verify the validity of the results reported. All authors state that we have absolutely no conflicts of interest (including financial, consultant, institutional and other relationships that might lead to bias or a conflict of interest). None of the authors received honoraria from a company or were on the speaker’s bureau for any Organization, and there were no sources of financial support, corporate involvement or patent holdings other than above mentioned grants from the Scientific Research Fund of Ministry of Health - Major Plan of Science and from above mentioned departmental sources. There was no support whatsoever from a pharmaceutical company or a manufacturer in any role whatsoever such as editing of the protocol, financial support, drug supply, data analysis or writing of the paper.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dahaba, A.A., Suljevic, I., Xiao, Z.Y. et al. Mindray 3-directional NMT Module (a new generation “Tri-axial” neuromuscular monitor) versus the Relaxometer mechanomyograph and versus the TOF-Watch SX acceleromyograph. J Clin Monit Comput 33, 853–862 (2019). https://doi.org/10.1007/s10877-018-0231-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10877-018-0231-3

Keywords

Navigation